Scholarlink

Purpose of the Review <p>Overactive bladder (OAB) affects ~ 33&#xa0;million Americans. Most studies enroll predominantly educated, non-Hispanic White women, limiting understanding of how social determinants, race/ethnicity, and structural inequities influence OAB burden and treatment. Evidence suggests disparities in prevalence, diagnosis, and guideline-based therapy reflect social and structural factors rather than biology.</p> Recent Findings <p>Literature from 2010 to 2025 notes higher OAB burden among Black, Hispanic, and lower-income women. Structural barriers (e.g., limited specialist access, high costs, restrictive insurance, and competing needs) reduce care-seeking and therapy adherence. Social and cultural factors, including stigma, mistrust, low health literacy, and language barriers, further limit engagement. Minority and low-income patients utilize pharmacologic and minimally invasive therapies less frequently despite greater symptom severity. Frailty affects treatment selection but does not appear to impact benefit. Strategies to address disparities include inclusive research, culturally tailored education, digital and community-based care, and patient navigators.</p> Summary <p> OAB disparities reflect intersecting structural, socioeconomic, and cultural factors. Equity requires inclusive research, responsive education, expanded access, and policy reform to address structural determinants.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Health Disparities and Overactive Bladder: Bridging the Gap

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月28日

查看全文
  • Susanna Gunamany,
  • Angeleque Hartt,
  • Rachel Kopkin,
  • Ibukunowola Omole,
  • Ekene A. Enemchukwu

摘要

Purpose of the Review

Overactive bladder (OAB) affects ~ 33 million Americans. Most studies enroll predominantly educated, non-Hispanic White women, limiting understanding of how social determinants, race/ethnicity, and structural inequities influence OAB burden and treatment. Evidence suggests disparities in prevalence, diagnosis, and guideline-based therapy reflect social and structural factors rather than biology.

Recent Findings

Literature from 2010 to 2025 notes higher OAB burden among Black, Hispanic, and lower-income women. Structural barriers (e.g., limited specialist access, high costs, restrictive insurance, and competing needs) reduce care-seeking and therapy adherence. Social and cultural factors, including stigma, mistrust, low health literacy, and language barriers, further limit engagement. Minority and low-income patients utilize pharmacologic and minimally invasive therapies less frequently despite greater symptom severity. Frailty affects treatment selection but does not appear to impact benefit. Strategies to address disparities include inclusive research, culturally tailored education, digital and community-based care, and patient navigators.

Summary

OAB disparities reflect intersecting structural, socioeconomic, and cultural factors. Equity requires inclusive research, responsive education, expanded access, and policy reform to address structural determinants.